Literature DB >> 12918759

Interferon alpha 2a in IRPB-derived peptide-induced EAU--part I.

Nicole Stübiger1, Isabel J Crane, Ina Kötter, Graeme R Lamont, Margot Zoeller, Ursula Günthert, John V Forrester, Manfred Zierhut, Rainer H Stiemer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12918759     DOI： 10.1007/0-306-48382-3_108

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

Review 1.  [Janus-faced?: Effects and side-effects of interferon therapy in ophthalmology].

Authors:  N Stübiger; S Winterhalter; U Pleyer; D Doycheva; M Zierhut; C Deuter
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

2.  Understanding autoimmunity in the eye: from animal models to novel therapies.

Authors:  Rachel R Caspi
Journal:  Discov Med       Date:  2014-03       Impact factor: 2.970

3.  Interferon-alpha2a and Vogt-Koyanagi-Harada disease: a double-edged sword?

Authors:  Valerie Touitou; Damien Sene; Christine Fardeau; Thi-Huong-Du Boutin; Pierre Duhaut; Jean-Charles Piette; Phuc LeHoang; Patrice Cacoub; Bahram Bodaghi
Journal:  Int Ophthalmol       Date:  2007-02-23       Impact factor: 2.029

4.  Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.

Authors:  Min Sun; Yan Yang; Peizeng Yang; Bo Lei; Liping Du; Aize Kijlstra
Journal:  PLoS One       Date:  2011-05-06       Impact factor: 3.240

5.  Interferons and their potential in the treatment of ocular inflammation.

Authors:  Friederike Mackensen; Regina Max; Matthias D Becker
Journal:  Clin Ophthalmol       Date:  2009-10-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.